Differential gene expression profiling in whole blood during acute systemic inflammation in lipopolysaccharide-treated rats

Physiological Genomics

Volumn 21, Issue , 2005, Pages 92-104

  Fannin, Rick D ^a   Auman, J Todd ^a   Bruno, Maribel E ^a   Sieber, Stella O ^a   Ward, Sandra M ^a   Tucker, Charles J ^a   Merrick, B Alex ^a   Paules, Richard S ^a  

^a NATIONAL INSTITUTE OF ENVIRONMENTAL HEALTH SCIENCES   (United States)

Author keywords

Methods; Microarray; Toxicogenomics

Indexed keywords

INTERLEUKIN 6; LIPOPOLYSACCHARIDE; RNA; TUMOR NECROSIS FACTOR ALPHA;

ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BLOOD CELL; CELL ADHESION; CELL POPULATION; CONTROLLED STUDY; CYTOSKELETON; DNA MICROARRAY; ENZYME LINKED IMMUNOSORBENT ASSAY; GENE CONTROL; GENE EXPRESSION PROFILING; GENETIC TRANSCRIPTION; HEMATOLOGY; INFLAMMATION; LEUKOCYTE; LYMPHOCYTOPENIA; MALE; NEUTROPHILIA; NONHUMAN; NUCLEOTIDE SEQUENCE; OXIDATION; PRIORITY JOURNAL; PROTEIN BLOOD LEVEL; RAT; RAT STRAIN; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; RNA ISOLATION; UNINDEXED SEQUENCE;

ANIMALS; CELL ADHESION; CLUSTER ANALYSIS; DNA, COMPLEMENTARY; ENZYME-LINKED IMMUNOSORBENT ASSAY; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION; INFLAMMATION; LIPOPOLYSACCHARIDES; MALE; MURIDAE; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; OXYGEN; PRINCIPAL COMPONENT ANALYSIS; RATS; RATS, SPRAGUE-DAWLEY; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA; TIME FACTORS;

ANIMALIA;

EID: 21244485403     PISSN: 15312267     EISSN: None     Source Type: Journal    
DOI: 10.1152/physiolgenomics.00190.2004     Document Type: Article

References (52)

1. Affymetrix. Technical Note: An Analysis of Blood Processing Methods to Prepare Samples for Genechip Expression Profiling, 2002. http://www.affymetrix. com/support/technical/technotesmain.affx.
2. Allcock GH, Allegra M, Flower RJ, and Perretti M. Neutrophil accumulation induced by bacterial lipopolysaccharide: effects of dexamethasone and annexin 1. Clin Exp Immunol 123: 62-67, 2001.
3. Auer H, Lyianarachchi S, Newsom D, Klisovic MI, Marcucci U, and Kornacker K. Chipping away at the chip bias: RNA degradation in microarray analysis. Nat Genet 35: 292-293, 2003.
4. Baechler EC, Batliwalla FM, Karypis G, Gaffney PM, Moser K, Ortmann WA, Espe KJ, Balasubramanian S, Hughes KM, Chan JP, Begovich A, Chang SY, Gregersen PK, and Behrens TW. Expression levels for many genes in human peripheral blood cells are highly sensitive to ex vivo incubation. Genes Immun 5: 347-353, 2004.
5. Beutler B. Endotoxin, toll-like receptor 4, and the afferent limb of innate immunity. Curr Opin Microbiol 3: 23-28, 2000.
6. Bushel PR, Hamadeh H, Bennett L, Sieber S, Martin K, Nuwaysir EF, Johnson K, Reynolds K, Paules RS, and Afshari CA. MAPS: a microarray project system for gene expression experiment information and data validation. Bioinformatics 17: 564-565, 2001.
7. Chen Y, Dougherty ER, and Bittner ML. Ratio-based decisions and the quantitative analysis of cDNA microarray images. J Biomed Opt 2: 364-374, 1997.
8. Chon H, Gaillard CAJM, van der Meijden BB, Dijstelbloem HM, Kraaijenhagen RJ, van Leenen D, Holstege FCP, Joles JA, Bluyssen HAR, Koomans HA, and Braam B. Broadly altered gene expression in blood leukocytes in essential hypertension is absent during treatment. Hypertension 43: 947-951, 2004.
9. Debey S, Schoenbeck U, Hellmich M, Gathof BS, Pillai R, Zander T, and Schultze JL. Comparison of different isolation techniques prior gene expression profiling of blood derived cells: impact on physiological responses, on overall expression and the role of different cell types. Pharmacogenomics J 4: 193-207, 2004.
10. Dragon S, Hille R, Gotz R, and Baumann R. Adenosine 3′:5′- cyclic monophosphate (cAMP)-inducible pyrimidine 5′-nucleotidase and pyrimidine nucleotide metabolism of chick embryonic erythrocytes. Blood 91: 3052-3058, 1998.
11. Duggan DJ, Bittner M, Chen Y, Meltzer P, and Trent JM. Expression profiling using cDNA microarrays. Nat Genet 21: 10-14, 1999.
12. Dziarski R, Platt KA, Gelius E, Steiner H, and Gupta D. Defect in neutrophil killing and increased susceptibility to infection with nonpathogenic gram-positive bacteria in peptidoglycan recognition protein-S (PGRP-S)-deficient mice. Blood 102: 689-697, 2003.
13. Eisen MB, Spellman PT, Brown PO, and Botstein D. Cluster analysis and display of genome-wide expression patterns. Proc Natl Acad Sci USA 95: 14863-14868, 1998,
14. Fessler MB, Malcolm KC, Duncan MW, and Worthen GS. A genomic and proteomic analysis of activation of the human neutrophil by lipopolysaccharide and its mediation by p38 mitogen-activated protein kinase. J Biol Chem 277: 31291-31302, 2002.
15. Fessler MB, Malcolm KC, Duncan MW, and Worthen GS. Lipopolysaccharide stimulation of the human neutrophil: an analysis of changes in gene transcription and protein expression by oligonucleotide microarrays and proteomics. Chest 121: 75S-76S, 2002.
16. Fujii J and Ikeda Y. Advances in our understanding of peroxiredoxin, a multifunctional, mammalian redox protein. Redox Rep 7: 123-130, 2002.
17. Gnatenko DV, Dunn JJ, McCorkle SR, Weissmann D, Perrotta PL, and Bahou WF. Transcript profiling of human platelets using microarray and serial analysis of gene expression. Blood 101: 2285-2293, 2003.
18. Grewal TS, Genever PG, Brabbs AC, Birch M, and Skerry TM. Best5: a novel interferon-inducible gene expressed during bone formation. FASEB J 14: 523-531, 2000.
19. Hamadeh HK, Knight BL, Haugen AC, Sieber S, Amin RP, Bushel PR, Stoll R, Blanchard K, Jayadev S, Tennant RW, Cunningham ML, Afshari CA, and Paules RS. Methapyrilene toxicity: anchorage of pathologic observations to gene expression alterations. Toxicol Pathol 30: 470-482, 2002.
20. Hino S, Kawamata H, Uchida D, Omotehara F, Miwa Y, Begum NM, Yoshida H, Fujimori T, and Sato M. Nuclear translocation of TSC-22 (TGF-β-stimulated clone-22) concomitant with apoptosis: TSC-22 as a putative transcriptional regulator. Biochem Biophys Res Commun 278: 659-664, 2000.
21. Jain NC. Clinical interpretation of changes in leukocyte numbers and morphology. In: Schalm's Veterinary Hematology (4th ed.), edited by Feldman BF, Zink JG, and Jain NC. Philadelphia, PA: Lea and Febiger. 1986, p. 831-837.
22. Jolliffe I. Principal Component Analysis. New York: Springer-Verlag. 1986.
23. Kakizaki Y, Watanobe H, Kohsaka A, and Suda T. Temporal profiles of interleukin-1β, interleukin-6, and tumor necrosis factor-α in the plasma and hypothalamic paraventricular nucleus after intravenous or intraperitoneal administration of lipopolysaccharide in the rat: estimation by push-pull perfusion. Endocr J 46: 487-496, 1999.
24. Krovat BC, Tracy JH, and Omiecinski CJ. Fingerprinting of cytochrome P450 and microsomal epoxide hydrolase gene expression in human blood cells. Toxicol Sci 55: 352-360, 2000.
25. Lampe JW, Stepaniants SB, Mao M, Radich JP, Dai H, Linsley PS, Friend SH, and Potter JD, Signatures of environmental exposures using peripheral leukocyte gene expression: tobacco smoke. Cancer Epidemiol Biomarkers Prev 13: 445-453, 2004.
26. Lu P, Nakorchevskiy A, and Marcotte EM. Expression deconvolution: a reinterpretation of DNA microarray data reveals dynamic changes in cell populations. Proc Natl Acad Sci USA 100: 10370-10375, 2003.
27. Malcolm KC, Arndt PG, Manos EJ, Jones DA, and Worthen GS. Microarray analysis of lipopolysaccharide-treated human neutrophils. Am J Physiol Lung Cell Mol Physiol 284: L663-L670, 2003.
28. Malcolm KC and Worthen GS. Lipopolysaccharide stimulates p38-dependent induction of antiviral genes in neutrophils independently of paracrine factors. J Biol Chem 278: 15693-15701, 2003.
29. Mijatovic T, Houzet L, Defrance P, Droogmans L, Huez G, and Kruys V. Tumor necrosis factor-α mRNA remains unstable and hypoadenylated upon stimulation of macrophages by lipopolysaccharides. Eur J Biochem 267: 6004-6012, 2000.
30. Moffett JR and Namboodiri MA. Tryptophan and the immune response. Immunol Cell Biol 81: 247-265, 2003.
31. Morgan ET, Li-Masters T, and Cheng PY. Mechanisms of cytochrome P450 regulation by inflammatory mediators. Toxicology 181-182: 207-210, 2002.
32. Nacken W, Roth J, Sorg C, and Kerkhoff C. S100A9/S100A8: myeloid representatives of the S100 protein family as prominent players in innate immunity. Microsc Res Tech 60: 569-580, 2003.
33. Pahl A and Brune K. Gene expression changes in blood after phlebotomy: implications for gene expression profiling. Blood 100: 1094-1095. 2002.
34. Preston GA, Waga I, Alcorta DA, Sasai H, Munger WE, Sullivan P, Phillips B, Jennette JC, and Falk RJ. Gene expression profiles of circulating leukocytes correlate with renal disease activity in IgA nephropathy. Kidney Int 65: 420-430, 2004.
35. Quansheng L and Nilsen-Hamilton M. Identification of a new acute phase protein. J Biol Chem 270: 22565-22570, 1995.
36. Qureshi NU, Dayao EK, Shirali S, Zukowska-Grojec Z, and Hauser GJ. Endogenous neuropeptide Y mediates vasoconstriction during endotoxic and hemorrhagic shock. Regul Pept 75-76: 215-220, 1998.
37. Rainen L, Oelmueller U, Jurgensen S, Wyrich R, Ballas C, Schram J, Herdman C, Bankaitis-Davis D, Nicholls N, Trollinger D, and Tryon V. Stabilization of mRNA expression in whole blood samples. Clin Chem 48: 1883-1890, 2002.
38. Salkowski CA and Vogel SN. Lipopolysaccharide increases glucocorticoid receptor expression in murine macrophages. A possible mechanism for glucocorticoid-mediated suppression of endotoxicity. J Immunol 149: 4041-4047, 1992.
39. Shapira L, Sylvia VL, Halabi A, Soskolne WA, Van Dyke TE, Dean DD, Boyan BD, and Schwartz Z. Bacterial lipopolysaccharide induces early and late activation of protein kinase C in inflammatory macrophages by selective activation of PKC-ε. Biochem Biophys Res Commun 240: 629-634, 1997.
40. Sherry B, Yarlett N, Strupp A, and Cerami A. Identification of cyclophilin as a proinflammatory secretory product of lipopolysaccharide- activated macrophages. Proc Natl Acad Sci USA 89: 3511-3515, 1992.
41. Smedegard G, Cui LX, and Hugli TE. Endotoxin-induced shock in the rat. A role for C5a. Am J Pathol 135: 489-497, 1989.
42. Stier S, Totzke G, Grunewald E, Neuhaus T, Fronhoffs S, Sachinidis A, Vetter H, Schulze-Osthoff K, and Ko Y. Identification of syntenin and other TNF-inducible genes in human umbilical arterial endothelial cells by suppression subtractive hybridization. FEBS Lett 467: 299-304, 2000.
43. 43a. Stockham SL. Hematologic changes due to bacterial infections. In: Schalm's Veterinary Hematology (5th ed.). edited by Feldman B, Zinkl J, and Jain N. Philadelphia, PA: Lippincott Williams and Wilkins, 2000, p. 38-43.
44. Ulich TR, del Castillo J, Keys M, Granger GA, and Ni RX. Kinetics and mechanisms of recombinant human interleukin 1 and tumor necrosis factor-α-induced changes in circulating numbers of neutrophils and lymphocytes. J Immunol 139: 3406-3415, 1987.
45. 2-terminal kinase is essential for the regulation of AP-1 by tumor necrosis factor. Mol Cell Biol 23: 2871-2882, 2003.
46. Venugopal R and Jaiswal AK. Nrf2 and Nrf1 in association with Jun proteins regulate antioxidant response element-mediated expression and coordinated induction of genes encoding detoxifying enzymes. Oncogens 17: 3145-3156, 1998.
47. 3-up-regulated protein-1 is a stress-responsive gene that regulates cardiomyocyte viability through interaction with thioredoxin. J Biol Chem 277: 26496-26500, 2002.
48. Whitney AR, Diehn M, Popper SJ, Alizadeh AA, Boldrick JC, Relman DA, and Brown PO. Individuality and variation in gene expression patterns in human blood. Proc Natl Acad Sci USA 100: 1896-1901, 2003.
49. Wilmore DW. Alterations in protein, carbohydrate, and fat metabolism in injured and septic patients. J Am Coll Nutr 2: 3-13, 1983.
50. Xu S and Venge P. Lipocalins as biochemical markers of disease. Biochim Biophys Acta 1482: 298-307, 2000.
51. Zhang H, Lu L, Enosawa S, Suzuki S, Takahara S, Toshiharu N, Saito H, and Sakamoto K. Comprehensive examination of gene expression associated with long-term stable graft acceptance by renal transplant recipients. Clin Transplant 18: 70-78, 2004.
52. Zhang T, Maekawa Y, Hanba J, Dainichi T, Nashed BF, Hisaeda H, Sakai T, Asao T, Himeno K, Good RA, and Katunuma N. Lysosomal cathepsin B plays an important role in antigen processing, while cathepsin D is involved in degradation of the invariant chain inovalbumin-immunized mice. Immunology 100: 13-20, 2000.